Synapse - Alexia Iasonos

Search Within

Alexia Elia Iasonos

Results (42)

Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers

Meeting Abstract

Choudhury, N. J.; Schneider, J. L.; Patil, T.; Zhu, V. W.; Goldman, D. A.; Yang, S. R.; Falcon, C.; Do, A.; Nie, Y.; Plodkowski, A. J.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study

Journal Article

Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Bevacizumab in advanced endometrial cancer

Journal Article

Rubinstein, M. M.; Dickinson, S.; Narayan, P.; Zhou, Q.; Iasonos, A.; Ma, W.; Lakhman, Y.; Makker, V.
Gynecologic Oncology (2021)

Fulltext@MSK | Save

Basket study of the oral progesterone antagonist onapristone ER in women with progesterone receptor positive (PR plus ) recurrent granulosa cell tumor (GCT), low-grade serous ovarian cancer (LGSOC), or endometrioid endometrial cancer (EEC)

Meeting Abstract

Grisham, R. N.; Li, K.; Iasonos, A.; Girshman, J.; Cadoo, K. A.; Kyi, C.; Makker, V.; Cohen, S. M.; O'Cearbhaill, R. E.; Sabbatini, P.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent high-grade and low-grade serous ovarian cancer

Meeting Abstract

Grisham, R. N.; Giri, D. D.; McDonnell, A.; Iasonos, A.; Zhou, Q.; Li, K.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Aghajanian, C.
Gynecologic Oncology (2020)

Fulltext@MSK | Save

A randomized phase II trial of secondary cytoreductive surgery (SCS) plus /- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC)

Meeting Abstract

Zivanovic, O.; Chi, D.; Zhou, Q.; Iasonos, A.; Makker, V.; Grisham, R. N.; Konner, J. A.; Diaz, J. P.; Brown, A. K.; Langstraat, C. L.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Positron lymphography via intracervical (18)F-FDG injection for presurgical lymphatic mapping in cervical and endometrial malignancies

Journal Article

Mueller, J. J.; Dauer, L. T.; Murali, R.; Iasonos, A.; Pandit-Taskar, N.; Abu-Rustum, N. R.; Grimm, J.
Journal of Nuclear Medicine (2020)

Fulltext@MSK | Save

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: A phase II trial

Journal Article

Zamarin, D.; Walderich, S.; Holland, A.; Zhou, Q.; Iasonos, A. E.; Torrisi, J. M.; Merghoub, T.; Chesebrough, L. F.; Mcdonnell, A. S.; Gallagher, J. M.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

Journal Article

Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway

Journal Article

Rubinstein, M. M.; Hyman, D. M.; Caird, I.; Won, H.; Soldan, K.; Seier, K.; Iasonos, A.; Tew, W. P.; O’Cearbhaill, R. E.; Grisham, R. N.; more...
Cancer (2020)

Fulltext@MSK | Save